Cyclopharm Successfully Completes A$14 million Placement
Filed with ASX · · 3 pages · English
In the deck
Story so far
Earlier from Cyclopharm
- CYC Unaudited Trading Update - Preliminary FY2025 Results
- Trading Halt
- COPD Study Leveraging Technegas and AI-Driven Lung Analysis
- Technegas Recognised in Updated Clinical Guideline
- Insurer Indemnifies Cyclopharm
Later from Cyclopharm
- Cyclopharm Capital Raising Investor Presentation
- Technegas Approved at the US National Institutes of Health
- Technegas US Footprint Expanding Across Four Regions
- Preliminary Final Report
- CYC Signs Enterprise Agreement with UPHS
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm